1 week ago
9
Reuters
Tue, December 9, 2025 astatine 5:37 AM CST 1 min read
Dec 9 (Reuters) - CVS Health (CVS) connected Tuesday forecast 2026 nett supra Wall Street estimates and this year's projected earnings, signalling dependable advancement successful the health conglomerate's turnaround plan.
CVS banal roseate much than 3% earlier the doorbell connected Tuesday.
The institution successful October projected double-digit net maturation for 2026 aft raising its 2025 profit forecast for the 3rd time.
"We are closing retired 2025 with meaningful momentum crossed our businesses and we expect different twelvemonth of beardown net maturation successful 2026," said Chief Financial Officer Brian Newman connected Tuesday.
NYSE - Delayed Quote USD
At close: December 8 astatine 4:00:02 PM EST
The institution forecast 2026 adjusted nett to beryllium successful the scope of $7.00 to $7.20 per share, compared with analysts' mean estimation of $7.16, according to information compiled by LSEG.
It, however, expects full gross of astatine slightest $400 cardinal adjacent year, beneath analysts' average estimation of $419.26 billion.
CVS besides raised its 2025 adjusted nett forecast to $6.60 to $6.70 per stock from $6.55 to $6.65 previously.
(Reporting by Sneha S K successful Bengaluru; Editing by Shinjini Ganguli)
English (CA) · 
English (US) · 
Spanish (MX) ·